These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19625958)

  • 1. Combination therapy for obesity and metabolic disease.
    Gadde KM; Allison DB
    Curr Opin Endocrinol Diabetes Obes; 2009 Oct; 16(5):353-8. PubMed ID: 19625958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New drug targets for the treatment of obesity.
    Powell AG; Apovian CM; Aronne LJ
    Clin Pharmacol Ther; 2011 Jul; 90(1):40-51. PubMed ID: 21654742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How physician obesity specialists use drugs to treat obesity.
    Hendricks EJ; Rothman RB; Greenway FL
    Obesity (Silver Spring); 2009 Sep; 17(9):1730-5. PubMed ID: 19300434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF21: a novel prospect for the treatment of metabolic diseases.
    Kharitonenkov A; Shanafelt AB
    Curr Opin Investig Drugs; 2009 Apr; 10(4):359-64. PubMed ID: 19337957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity pharmacotherapy from a regulatory perspective: overview and key challenges.
    Hutchinson NI; Ryder SW
    Clin Pharmacol Ther; 2007 May; 81(5):756-60. PubMed ID: 17392723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination pharmaceutical therapies for obesity.
    Gadde KM; Allison DB
    Expert Opin Pharmacother; 2009 Apr; 10(6):921-5. PubMed ID: 19351275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lorcaserin and adiposopathy: 5-HT2c agonism as a treatment for 'sick fat' and metabolic disease.
    Bays HE
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1429-45. PubMed ID: 19900026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational design of a combination medication for the treatment of obesity.
    Greenway FL; Whitehouse MJ; Guttadauria M; Anderson JW; Atkinson RL; Fujioka K; Gadde KM; Gupta AK; O'Neil P; Schumacher D; Smith D; Dunayevich E; Tollefson GD; Weber E; Cowley MA
    Obesity (Silver Spring); 2009 Jan; 17(1):30-9. PubMed ID: 18997675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in the discovery and development of new agents for the treatment of obesity.
    Staten MA
    Clin Pharmacol Ther; 2007 May; 81(5):753-5. PubMed ID: 17377527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The obesity pipeline: current strategies in the development of anti-obesity drugs.
    Cooke D; Bloom S
    Nat Rev Drug Discov; 2006 Nov; 5(11):919-31. PubMed ID: 17080028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging pharmacotherapy for obesity.
    Aronne LJ; Powell AG; Apovian CM
    Expert Opin Emerg Drugs; 2011 Sep; 16(3):587-96. PubMed ID: 21834735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical therapy for obesity--current status and future hopes.
    Bray GA
    Med Clin North Am; 2007 Nov; 91(6):1225-53, xi. PubMed ID: 17964918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavior therapy for obesity: where are we now?
    Sarwer DB; von Sydow Green A; Vetter ML; Wadden TA
    Curr Opin Endocrinol Diabetes Obes; 2009 Oct; 16(5):347-52. PubMed ID: 19623061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical versus surgical interventions for the metabolic complications of obesity in children.
    Dixon JB; Jones K; Dixon M
    Semin Pediatr Surg; 2009 Aug; 18(3):168-75. PubMed ID: 19573759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trial success rates of anti-obesity agents: the importance of combination therapies.
    Hussain HT; Parker JL; Sharma AM
    Obes Rev; 2015 Sep; 16(9):707-14. PubMed ID: 26222385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medications for weight reduction.
    Bray GA
    Endocrinol Metab Clin North Am; 2008 Dec; 37(4):923-42. PubMed ID: 19026940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of late-stage CNS drug candidates for the treatment of obesity.
    Heal DJ; Gosden J; Smith SL
    Int J Obes (Lond); 2013 Jan; 37(1):107-17. PubMed ID: 22410963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting hyperglycaemia with anti-obesity drugs: time for a paradigm shift?
    Krentz AJ; Hompesch M
    Drugs; 2013 Oct; 73(15):1649-51. PubMed ID: 24092613
    [No Abstract]   [Full Text] [Related]  

  • 19. Dirlotapide: a review of its properties and role in the management of obesity in dogs.
    Wren JA; Gossellin J; Sunderland SJ
    J Vet Pharmacol Ther; 2007 Aug; 30 Suppl 1():11-6. PubMed ID: 17567510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plants popularly used for loosing weight purposes in Porto Alegre, South Brazil.
    Dickel ML; Rates SM; Ritter MR
    J Ethnopharmacol; 2007 Jan; 109(1):60-71. PubMed ID: 16963210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.